 |
|
|
| |
Efficacy and Safety of an Interferon-Free Regimen of MK-5172 + Ribavirin for 12 Weeks or 24 Weeks in Treatment-Naive, Noncirrhotic Subjects With HCV GT1 Infection: The C-SPIRIT Study
|
| |
| |
Reported by Jules Levin
Asian Pacific Association for The Study of the Liver,
Brisbane, Australia
12-15 March, 2014
Edward Gane, Ziv Ben Ari, Lindsay Mollison, Eli Zuckerman, Rafael Bruck, Yaacov Baruch, Janice Wahl, Sanhita Bhanja, Peggy Hwang, Yue Zhao, Michael N. Robertson
|
| |
|
|
|
|
|
